MAS
TEVA icon

Managed Account Services’s Teva Pharmaceuticals TEVA Stock Holding History

Managed Account Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,000
Closed -$109K – 112
2021
Q2 		$109K Hold
11,000
– – 0.03% 109
2021
Q1 		$127K Hold
11,000
– – 0.03% 102
2020
Q4 		$134K Hold
11,000
– – 0.04% 106
2020
Q3 		$103K Hold
11,000
– – 0.03% 95
2020
Q2 		$126K Hold
11,000
– – 0.05% 92
2020
Q1 		$92K Hold
11,000
– – 0.04% 85
2019
Q4 		$99K Hold
11,000
– – 0.04% 86
2019
Q3 		$76K Hold
11,000
– – 0.04% 86
2019
Q2 		$104K Hold
11,000
– – 0.06% 84
2019
Q1 		$160K Hold
11,000
– – 0.09% 84
2018
Q4 		$207K Hold
11,000
– – 0.13% 74
2018
Q3 		$234K Buy
+11,000
New +$255K 0.15% 70
2018
Q2 		– Sell
-11,200
Closed -$191K – 72
2018
Q1 		$191K Hold
11,200
– – 0.13% 70
2017
Q4 		$212K Sell
11,200
-413
-4% -$6.21K 0.14% 70
2017
Q3 		$204K Sell
11,613
-3,298
-22% -$74.2K 0.14% 61
2017
Q2 		$495K Buy
14,911
+211
+1% +$6.53K 0.35% 47
2017
Q1 		$472K Hold
14,700
– – 0.35% 47
2016
Q4 		$533K Buy
+14,700
New +$587K 0.41% 45

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Managed Account Services's TEVA Position: Q3 2021 in Review

Managed Account Services sold out of Teva Pharmaceuticals (TEVA) in Q3 2021, closing a stake of 11,000 shares — an estimated $109K sold.

Managed Account Services first reported a position in TEVA in Q4 2016 and held it in 18 quarters. The position peaked at $533K in Q4 2016. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Managed Account Services reported no remaining Teva Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Managed Account Services sold 11,000 Teva Pharmaceuticals shares in Q3 2021, an estimated $109K.
  • Managed Account Services first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 18 quarters.
  • Managed Account Services's Teva Pharmaceuticals position peaked at $533K in Q4 2016.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Managed Account Services's 13F filing for Q3 2021, filed 9 Nov 2021.